Gold Bond Psoriasis Relief Medicated Multi-Symptom
- Product NDC
- 41167-0413
- 11-digit product format
- 411670413
- Labeler code
- 41167
- Product ID
- 41167-0413_a4965a60-d05e-45c3-8f0c-0e39f5efbf6e
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Salicylic Acid
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- Chattem, Inc.
- Application
- M032
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2022-08-01
- Substance
- SALICYLIC ACID
- Active strength
- 3 g/100g
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Gold Bond Psoriasis Relief Medicated Multi-Symptom
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| SALICYLIC ACID | 3 g/100g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | O414PZ4LPZ |
| Rxcui | 416910 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 41167-0413-2 | Gold Bond Psoriasis Relief Medicated Multi-Symptom | 113 g in 1 TUBE | CREAM | 113 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 41167-0413 | GOLD BOND PSORIASIS RELIEF MEDICATED MULTI-SYMPTOM (SALICYLIC ACID) CREAM [CHATTEM, INC.] | 1 | Current NDC, 1 package rows | 20250322_e8479bbc-5f49-41f2-851e-a93543516639.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 41167-0413-2 | 41167041302 | 113 g in 1 TUBE (41167-0413-2) | 113 g | 2022-08-01 | No | No | Historical |